Cargando…

Association Between BDNF Gene Variant Rs6265 and the Severity of Depression in Antidepressant Treatment-Free Depressed Patients

BACKGROUND: Brain-derived neurotrophic factor (BDNF) plays an important role in neuronal plasticity, and its dysregulation has been associated with the pathogenesis of mood and anxiety disorders. Prolactin (PRL) is a pituitary hormone which is also produced as a cytokine by immune cells and could be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Losenkov, Innokentiy S., Mulder, Nathaniël J. V., Levchuk, Lyudmila A., Vyalova, Natalya M., Loonen, Anton J. M., Bosker, Fokko J., Simutkin, German G., Boiko, Anastasiia S., Bokhan, Nikolay A., Wilffert, Bob, Hak, Eelko, Schmidt, Amand F., Ivanova, Svetlana A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028755/ https://www.ncbi.nlm.nih.gov/pubmed/32116853 http://dx.doi.org/10.3389/fpsyt.2020.00038

Ejemplares similares

The functional variant rs334558 of GSK3B is associated with remission in patients with depressive disorders
por: Levchenko, Anastasia, et al.
Publicado: (2018)

Limited Associations Between 5-HT Receptor Gene Polymorphisms and Treatment Response in Antidepressant Treatment-Free Patients With Depression
por: Ochi, Taichi, et al.
Publicado: (2019)

Beta-Endorphin and Oxytocin in Patients with Alcohol Use Disorder and Comorbid Depression
por: Roschina, Olga V., et al.
Publicado: (2021)

Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment‐free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic design
por: Geers, Lisanne M., et al.
Publicado: (2021)

Preliminary Pharmacogenetic Study to Explore Putative Dopaminergic Mechanisms of Antidepressant Action
por: Ochi, Taichi, et al.
Publicado: (2021)

Exploring Brain Derived Neurotrophic Factor and Cell Adhesion Molecules as Biomarkers for the Transdiagnostic Symptom Anhedonia in Alcohol Use Disorder and Comorbid Depression
por: Levchuk, Lyudmila A., et al.
Publicado: (2020)

Association of Single Nucleotide Polymorphisms of Cytokine Genes with Depression, Schizophrenia and Bipolar Disorder
por: Mikhalitskaya, Ekaterina V., et al.
Publicado: (2023)

Exploring the paradigm of depressive disorders through an evolutionary and biopsychosocial lens
por: Ochi, T., et al.
Publicado: (2023)

Serum BDNF’s Role as a Biomarker for Motor Training in the Context of AR-Based Rehabilitation after Ischemic Stroke
por: Koroleva, Ekaterina S., et al.
Publicado: (2020)

NRG1, PIP4K2A, and HTR2C as Potential Candidate Biomarker Genes for Several Clinical Subphenotypes of Depression and Bipolar Disorder
por: Levchenko, Anastasia, et al.
Publicado: (2020)

Serum Levels of S100B Protein and Myelin Basic Protein as a Potential Biomarkers of Recurrent Depressive Disorders
por: Levchuk, Lyudmila A., et al.
Publicado: (2023)

A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia
por: Osmanova, Diana Z., et al.
Publicado: (2019)

Association of ANKK1 polymorphism with antipsychotic‐induced hyperprolactinemia
por: Fedorenko, Olga Yu., et al.
Publicado: (2020)

The BDNF Val66Met polymorphism (rs6265) enhances dopamine neuron graft efficacy and side-effect liability in rs6265 knock-in rats
por: Mercado, Natosha M., et al.
Publicado: (2020)

Remaining Need for In Vitro Test to Elucidate 5-Hydroxytryptamine 2C Receptor Functioning
por: Ivanova, Svetlana A., et al.
Publicado: (2018)

The BDNF rs6265 Polymorphism is a Modifier of Cardiomyocyte Contractility and Dilated Cardiomyopathy
por: Raucci, Frank J., et al.
Publicado: (2020)

A New Paradigm to Indicate Antidepressant Treatments
por: Loonen, Anton J. M., et al.
Publicado: (2021)

Genetic polymorphisms of PIP5K2A and course of schizophrenia
por: Poltavskaya, Evgeniya G., et al.
Publicado: (2020)

BDNF rs6265 Polymorphism and Its Methylation in Patients with Stroke Undergoing Rehabilitation
por: Santoro, Massimo, et al.
Publicado: (2020)

Neuron-specific enolase during the therapy in patients with alcohol use disorder and mood disorders
por: Levchuk, L., et al.
Publicado: (2021)

PM515. The association between serotonin receptor gene polymorphisms and hyperprolactinemia in antipsychotic drug-treated schizophrenic patients
por: Ivanova, Svetlana, et al.
Publicado: (2016)

Association of Cholinergic Muscarinic M4 Receptor Gene Polymorphism with Schizophrenia
por: Pozhidaev, Ivan V, et al.
Publicado: (2020)

Association between BDNF rs6265 and Obesity in the Boston Puerto Rican Health Study
por: Ma, Xian-Yong, et al.
Publicado: (2012)

Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia
por: Boiko, Anastasiia S., et al.
Publicado: (2019)

Cortisol and DHEAS Related to Metabolic Syndrome in Patients with Schizophrenia
por: Boiko, Anastasiia S, et al.
Publicado: (2020)

SIRT1 Allele Frequencies in Depressed Patients of European Descent in Russia
por: Aftanas, Lyubomir I., et al.
Publicado: (2019)

Association between 8 P‐glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug‐induced hyperprolactinaemia
por: Geers, Lisanne M., et al.
Publicado: (2020)

BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression
por: Nociti, Viviana, et al.
Publicado: (2018)

Association between BDNF rs6265 polymorphisms and postoperative cognitive dysfunction in Chinese Han Population
por: Xie, Songhui, et al.
Publicado: (2020)

The rs6265 Polymorphism of the BDNF Gene Is Related to Higher-Lethality Suicide Attempts in the Korean Population
por: Kang, Seung-Gul, et al.
Publicado: (2020)

Adipocytokines and Metabolic Syndrome in Patients with Schizophrenia
por: Mednova, Irina A., et al.
Publicado: (2020)

Significant association of BDNF rs6265 G>A polymorphism with susceptibility to epilepsy: a meta-analysis
por: Xu, Yue-Long, et al.
Publicado: (2018)

Correction: BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression
por: Nociti, Viviana, et al.
Publicado: (2019)

Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics
por: Boiko, Anastasiia S., et al.
Publicado: (2021)

Exploration of the Moderating Effects of Physical Activity and Early Life Stress on the Relation between Brain-Derived Neurotrophic Factor (BDNF) rs6265 Variants and Depressive Symptoms among Adolescents
por: Soler, Catalina Torres, et al.
Publicado: (2022)

The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis
por: Dolcetti, Ettore, et al.
Publicado: (2022)

N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial
por: Yang, Chenghao, et al.
Publicado: (2018)

Serum Growth Factors in Schizophrenia Patients
por: Boiko, Anastasiia S., et al.
Publicado: (2023)

Circuits Regulating Pleasure and Happiness—Mechanisms of Depression
por: Loonen, Anton J. M., et al.
Publicado: (2016)

An Analysis of Five TrkB Gene Polymorphisms in Schizophrenia and the Interaction of Its Haplotype with rs6265 BDNF Gene Polymorphism
por: Suchanek-Raif, Renata, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0qtsgeft5dl4sgkmfgmiprkccf